Kenvue (KVUE) has drawn investor attention after recent share performance data showed the stock flat over 1 day, down about 3% over the past week, and weaker over the past year.

At a share price of US$17.19, Kenvue’s recent 7 day and 90 day share price returns, which declined 2.99% and 8.07% respectively, line up with a weaker 1 year total shareholder return that fell 24.68%. This suggests fading momentum as investors reassess its risk and return profile.

If this shift in sentiment has you rethinking your watchlist, it could be a good moment to scan the market for other ideas using our 19 top founder-led companies

With Kenvue trading at US$17.19 and indicators like intrinsic discount and analyst targets pointing to a gap, the key question is simple: is this a potential value opportunity, or is the market already pricing in future growth?

Most Popular Narrative: 31.5% Undervalued

According to the widely followed narrative, Kenvue’s fair value sits at $25.09, well above the recent close at $17.19, which frames the current valuation debate.

With autonomy from its former parent, Kenvue can allocate resources to best fit its needs and grow the business.

Macro drivers like an aging population and premiumization of health care will act as tailwinds for all of Kenvue’s brands.

Want to see what is baked into that fair value gap? The narrative leans on revenue growth, firmer profit margins and a future earnings multiple that assumes real staying power.

According to julio, the narrative prices Kenvue using a discount rate that reflects its consumer health profile and applies firm assumptions on revenue growth and profitability to justify a fair value of $25.09 per share.

Result: Fair Value of $25.09 (UNDERVALUED)

However, there are still pressure points, including higher input costs that could push shoppers toward cheaper alternatives and lingering reputational risk from past talc-related litigation.

Another View: What Earnings Multiples Are Saying

While the user narrative points to a $25.09 fair value, the current P/E ratio of 20.3x sends a different signal. It sits above the global Personal Products industry at 19.4x and the peer average at 15.1x, and it is very close to the 20.4x fair ratio.

In practice, that means the stock trades richer than many direct peers, yet roughly in line with where the fair ratio suggests the market could settle. This raises a practical question for you: is this a margin of safety, or a sign that expectations are already full?

Next Steps

Sentiment on Kenvue is clearly mixed, with both risks and rewards on the table. It makes sense to review the details now and weigh the 3 key rewards and 2 important warning signs

Looking for more investment ideas?

If Kenvue has you rethinking your next move, do not stop here. Broaden your watchlist now so you are not late to the next opportunity.

• Target resilient income by scanning for 13 dividend fortresses that could help anchor your portfolio with consistent cash flows.
• Hunt for potential mispriced opportunities through the 48 high quality undervalued stocks and see which stocks the data suggests might be trading below their fundamentals.
• Spot resilient operators using the 67 resilient stocks with low risk scores and focus your research on companies with lower risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.